Zentalis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.About ZNTL
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations.
ZNTL Key Statistics
Stock Snapshot
As of today, Zentalis Pharmaceuticals(ZNTL) shares are valued at $4.37. The company's market cap stands at 314.22M, with a P/E ratio of -2.32.
On 2026-04-10, Zentalis Pharmaceuticals(ZNTL) stock traded between a low of $4.37 and a high of $4.54. Shares are currently priced at $4.37, which is +0.0% above the low and -3.8% below the high.
Zentalis Pharmaceuticals(ZNTL) shares are trading with a volume of 109.2K, against a daily average of 2.08M.
During the past year, Zentalis Pharmaceuticals(ZNTL) stock moved between $1.06 at its lowest and $4.54 at its peak.
During the past year, Zentalis Pharmaceuticals(ZNTL) stock moved between $1.06 at its lowest and $4.54 at its peak.
Analyst ratings
56%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.